US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

THEMES US R&D CHAMPIONS ETF

37.24

0.0000

Volume:- -

Turnover:- -

Market Cap:1.12M

PE:- -

High:37.24

Open:37.24

Low:37.24

Close:37.24

52wk High:39.83

52wk Low:30.96

Shares:30.00K

Float Shares:30.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:0.14

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

THX Pharma Secures Long-Term European Patent Protection for Batten-1

Guangxi Courts Intensify IP Safeguards to Shield Innovation Achievements

Bergen Carbon Solutions Secures Key Patent for Carbon Purification Technology

Judge rejects Altria’s challenge to ITC patent probes, Bloomberg reports

Cyngn provides overview of its U.S. patent portfolio

BioNTX and PatentVest Announce Multi-Year Strategic Partnership

First Hydrogen Secures Exclusive Rights to AI-Driven Ground Drone Platform

HCW Biologics receives patent allowance for alopecia areata drug

AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041

Purple Biotech issued notice of allowance from USPTO

New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies

Lightbridge receives notice of allowance on new Japanese patent

CreeLED, Promeir Products resolve patent dispute via limited license agreement

BioMarin to receive 20% royalty on net sales of Yuviwel from Ascendis Pharma

10x Genomics reports patent infringement win against Parse Biosciences

UAE Accepts Alar's Patent Acceptance for Long-Acting Ketamine Injectable Formulations

MT Newswires Live

Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment

Northstar Secures New U.S. Patent for Asphalt Shingle Reprocessing Technology

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/USRD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"USRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","market":"US","secType":"STK","nameCN":"THEMES US R&D CHAMPIONS ETF","latestPrice":37.237,"timestamp":1789070400000,"preClose":37.237,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"Pre-Mkt","change":0,"latestTime":"09-11 06:22:30 EDT","open":37.237,"high":37.237,"low":37.237,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":37.237,"sharesOutstanding":30000,"nav":37.28,"aum":1118400,"dividendRate":0.003776,"bidAskSpread":0,"volumeRatio":0,"impliedVol":0.1087,"impliedVolPercentile":0.1892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","floatShares":30000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.1406,"high":37.237,"amplitude":0,"preClose":37.237,"low":37.237,"week52Low":30.96,"pbRate":"--","week52High":39.83,"institutionHeld":0,"latestPrice":37.237,"eps":0,"divideRate":0.003776,"volume":0,"delay":0,"ttmEps":0,"open":37.237,"prevYearClose":33.9934,"prevWeekClose":37.237,"prevMonthClose":37.237,"prevQuarterClose":37.1571,"fiveDayClose":37.237,"twentyDayClose":37.237,"sixtyDayClose":38.2265},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/USRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-29","symbol":"USRD","reason":null,"defaultRemindTime":1785331800000,"announcedDate":"2026-07-28","type":"delisting","dateTimestamp":1785297600000},{"date":"2025-12-18","symbol":"USRD","amount":0.1402666,"announcedDate":"2025-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-18","defaultRemindTime":1766068200000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-18","currency":"USD","dateTimestamp":1766034000000,"payDate":"2025-12-19"},{"date":"2024-12-24","symbol":"USRD","amount":0.72425,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"USRD\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.72425,"currency":"USD"},{"executeDate":"2025-12-18","recordDate":"2025-12-18","paymentDate":"2025-12-19","value":0.1402666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"USRD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"USRD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666759267","title":"Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666759267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666759267?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:57","pubTimestamp":1789055857,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals'  patent on Eylea HD is more likely to be retained, with the Patent Trial and Appeal Board, or PTAB, due to issue a final decision on an ongoing patent dispute by March 2027, RBC Capital Markets said in a Thursday note.The patent, which covers Eylea HD's formulation and method of treatment, was issued in 2024 and is set to expire May 10, 2039, according to the note. Alvotech  has challenged the patent, with the PTAB to hear arguments on Dec. 4 and issue a decision by March 3, 2027, the brokerage said.\"Our read and feedback suggests Regeneron is likely in a stronger position, particularly against Alvotech's prior art arguments,\" RBC said. The patent serves as the company's strongest defense for Eylea HD, blocking potential biosimilars, the investment firm noted.RBC has a sector perform rating on Regeneron Pharmaceuticals, with a $737 price target.Price: 795.00, Change: -12.65, Percent Change: -1.57","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBH","LU0053666078.USD","LU0823434583.USD","LU0889565916.HKD","TBXU","USRD","LU2237438978.USD","ALVO","LU0058720904.USD","LU1917777945.USD","LU0823434740.USD","LU2106854487.HKD","LU2023250504.SGD","IBB","LU0882574055.USD","IBBQ","LU2362541513.USD","LU0114720955.EUR","LU0109394709.USD","REGN","LU0289739699.SGD","LU1974910355.USD","LU2362541273.HKD","LU0320765992.SGD","LU2089984988.USD","BK4139","BK4585","LU2468319806.SGD","BK4588","LU2362540622.SGD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533142","title":"Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533142?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"Patient dosing commenced in the DReAMzz Phase 2 dose-optimization study of IHL-42X in obstructive sleep apneaU.S. composition and methods of treatment patent granted covering IHL-42X with baseline exp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358577/0/en/incannex-healthcare-provides-corporate-update-on-clinical-progress-intellectual-property-and-capital-position.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","XLV","BK4588","LU2065732104.USD","LU0029874061.USD","BK4137","BK4097","USRD","XBI","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666058852","title":"THX Pharma Secures Long-Term European Patent Protection for Batten-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2666058852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666058852?lang=en_us&edition=fundamental","pubTime":"2026-09-09 15:08","pubTimestamp":1788937732,"startTime":"0","endTime":"0","summary":"Theranexus SA ( ($FR:ALTHX) ) has shared an announcement. THX Pharma and the Beyond Batten Disease Foundation have secured a key European patent pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/thx-pharma-secures-long-term-european-patent-protection-for-batten-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/thx-pharma-secures-long-term-european-patent-protection-for-batten-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPV","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144074639","title":"Guangxi Courts Intensify IP Safeguards to Shield Innovation Achievements","url":"https://stock-news.laohu8.com/highlight/detail?id=1144074639","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144074639?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:31","pubTimestamp":1788849074,"startTime":"0","endTime":"0","summary":"Guangxi courts have significantly bolstered their intellectual property protections, tackling infringement cases to foster a fairer market environment supporting homegrown breakthroughs.Zhang...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD","PTNT","BK4139","LRND","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313418","title":"Bergen Carbon Solutions Secures Key Patent for Carbon Purification Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313418?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:37","pubTimestamp":1788773860,"startTime":"0","endTime":"0","summary":"An announcement from Bergen Carbon Solutions AS ( ($DE:7X7) ) is now available. Bergen Carbon Solutions AS has secured a patent from the Norwegian ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bergen-carbon-solutions-secures-key-patent-for-carbon-purification-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bergen-carbon-solutions-secures-key-patent-for-carbon-purification-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","AS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665355876","title":"Judge rejects Altria’s challenge to ITC patent probes, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665355876","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665355876?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:45","pubTimestamp":1788540311,"startTime":"0","endTime":"0","summary":"Judge Robert E. Payne of the U.S. District Court for the Eastern District of Virginia rejected Altria’s claim that the U.S. International Trade Com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/judge-rejects-altrias-challenge-to-itc-patent-probes-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/judge-rejects-altrias-challenge-to-itc-patent-probes-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664366339","title":"Cyngn provides overview of its U.S. patent portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2664366339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664366339?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:10","pubTimestamp":1788520214,"startTime":"0","endTime":"0","summary":"Cyngn (CYN) provided an overview of its U.S. patent portfolio, which has grown to 24 issued patents following its most recent grant in March 2026. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cyngn-provides-overview-of-its-u-s-patent-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cyngn-provides-overview-of-its-u-s-patent-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CYN","BK4023","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870539","title":"BioNTX and PatentVest Announce Multi-Year Strategic Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870539","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870539?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:00","pubTimestamp":1788444000,"startTime":"0","endTime":"0","summary":"Collaboration will strengthen the Rising Stars platform through structured intellectual property diligence, commercialization-focused assessments, and year-round founder supportDALLAS, Texas, Sept.  0","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356057/0/en/biontx-and-patentvest-announce-multi-year-strategic-partnership.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTI","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150846","title":"First Hydrogen Secures Exclusive Rights to AI-Driven Ground Drone Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150846","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150846?lang=en_us&edition=fundamental","pubTime":"2026-09-03 03:03","pubTimestamp":1788375794,"startTime":"0","endTime":"0","summary":"The latest update is out from First Hydrogen ( ($TSE:FHYD) ). First Hydrogen Corp. has secured exclusive worldwide rights to commercialize a patent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/first-hydrogen-secures-exclusive-rights-to-ai-driven-ground-drone-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/first-hydrogen-secures-exclusive-rights-to-ai-driven-ground-drone-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","HYDR","ARTY","AGIX","AIPO","USRD","VTHR","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812486","title":"HCW Biologics receives patent allowance for alopecia areata drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812486?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:20","pubTimestamp":1788355222,"startTime":"0","endTime":"0","summary":"HCW Biologics (HCWB) announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for claims directed to use of HCW9302 to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hcw-biologics-receives-patent-allowance-for-alopecia-areata-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hcw-biologics-receives-patent-allowance-for-alopecia-areata-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","HCWB","BK4139","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812533","title":"AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812533","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812533?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:43","pubTimestamp":1788352980,"startTime":"0","endTime":"0","summary":"Patent protections establish long-duration intellectual property coverage for Ampligen across major European markets and the United Kingdom Latest milestone further strengthens AIM’s expanding global ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355163/29489/en/aim-immunotech-significantly-expands-ampligen-global-patent-estate-with-long-covid-protection-across-europe-and-the-united-kingdom-through-2041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBCP","USRD","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664462819","title":"Purple Biotech issued notice of allowance from USPTO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664462819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664462819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:50","pubTimestamp":1788349821,"startTime":"0","endTime":"0","summary":"Purple Biotech (PPBT) announced that the U.S. Patent and Trademark Office, or USPTO, has issued a notice of allowance for a patent application cove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/purple-biotech-issued-notice-of-allowance-from-uspto-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/purple-biotech-issued-notice-of-allowance-from-uspto-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","BK4581","XBI","BK4588","BK4007","BK4585","PPBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664195608","title":"New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2664195608","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664195608?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348600,"startTime":"0","endTime":"0","summary":"REHOVOT, Israel, Sept.  02, 2026 (GLOBE NEWSWIRE) --  Purple Biotech Ltd.(\"Purple Biotech\" or the “Company\") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy pl","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355018/0/en/new-u-s-patent-allowance-strengthens-protection-for-captn-3-modular-platform-for-next-generation-multispecific-antibodies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855680","title":"Lightbridge receives notice of allowance on new Japanese patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855680?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:10","pubTimestamp":1788261019,"startTime":"0","endTime":"0","summary":"Lightbridge (LTBR)announced that it has received a notice of allowance from the Japan Patent Office, or JPO, for Japanese Patent Application No. 20...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lightbridge-receives-notice-of-allowance-on-new-japanese-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lightbridge-receives-notice-of-allowance-on-new-japanese-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTBR","JPMO","USRD","BK4156","JPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664622007","title":"CreeLED, Promeir Products resolve patent dispute via limited license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664622007","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664622007?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:05","pubTimestamp":1788195913,"startTime":"0","endTime":"0","summary":"Cree LED and Promier Products announced that they have reached a mutually beneficial settlement resolving a patent infringement dispute involving C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creeled-promeir-products-resolve-patent-dispute-via-limited-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creeled-promeir-products-resolve-patent-dispute-via-limited-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","USRD","PTNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663294076","title":"BioMarin to receive 20% royalty on net sales of Yuviwel from Ascendis Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2663294076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663294076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:15","pubTimestamp":1788167708,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) announced that it has entered into binding terms with Ascendis Pharma (ASND), resolving the patent and ancillary disputes pending g...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarin-to-receive-20-royalty-on-net-sales-of-yuviwel-from-ascendis-pharma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarin-to-receive-20-royalty-on-net-sales-of-yuviwel-from-ascendis-pharma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASND","MEDI","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","USRD","IE00B19Z3581.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BMRN","BK4566","IE0002270589.USD","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018795","title":"10x Genomics reports patent infringement win against Parse Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018795","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018795?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:45","pubTimestamp":1787942712,"startTime":"0","endTime":"0","summary":"10x Genomics (TXG) announced that a jury in the U.S. District Court for the District of Delaware found that Parse Biosciences, now a subsidiary of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/10x-genomics-reports-patent-infringement-win-against-parse-biosciences-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/10x-genomics-reports-patent-infringement-win-against-parse-biosciences-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1861558580.USD","BK4121","LU0963586101.USD","TXG","ARKG","LU1861559042.SGD","USRD","BK4548","FMED","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050308","title":"UAE Accepts Alar's Patent Acceptance for Long-Acting Ketamine Injectable Formulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050308","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050308?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:23","pubTimestamp":1787905434,"startTime":"0","endTime":"0","summary":"Alar Pharmaceuticals  received a notice of acceptance from the UAE Ministry of Economy and Tourism for a patent covering long-acting injectable formulations of ketamine pamoate salts.The company said the patent could facilitate its international licensing business, according to a Friday Taiwan Exchange filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UAE","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084341","title":"Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084341","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084341?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:10","pubTimestamp":1787847015,"startTime":"0","endTime":"0","summary":"“Psychedelic” is The Fly’s recurring series focused on psychedelic stock news. SCISPARC/CLEARMIND: SciSparc (SPRC) announced earlier this week that...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-scisparc-clearmind-publish-patent-application-for-ptsd-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-scisparc-clearmind-publish-patent-application-for-ptsd-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","USRD","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706325","title":"Northstar Secures New U.S. Patent for Asphalt Shingle Reprocessing Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706325","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706325?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826867,"startTime":"0","endTime":"0","summary":"An update from Northstar Clean Technologies ( ($TSE:ROOF) ) is now available. Northstar Clean Technologies has been awarded a new U.S. patent for i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/northstar-secures-new-u-s-patent-for-asphalt-shingle-reprocessing-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/northstar-secures-new-u-s-patent-for-asphalt-shingle-reprocessing-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":137,"code":"91000000","status":"200"}]}}